Valsartan is commonly used to treat high blood pressure and heart failure. However, in July 2018 the FDA issued a major recall on valsartan medications, after discovering that many contained a dangerous carcinogen called N-nitrosodimethylamine (NDMA).
Valsartan Recall Continues To Expand
Failing to diagnose breast cancer can hurt a patient's prognosis
Receiving a diagnosis for a serious cancer, such as breast cancer, is never what you want to experience at the doctor's office. You hope that your concerns are not the result of anything serious. However, failing to get a diagnosis that accurately reflects your condition could have a profound impact on your prognosis.
